Semaglutide Improves Vascular and Liver Health in Type 2 Diabetes
Author Information
Author(s): Ishaq Muhammad Umer, Fatima Noor, Sharif Rida, Awais Warda
Primary Institution: Nishtar Medical College, Nishtar Medical University
Hypothesis
Does semaglutide improve vascular and liver indices in patients with type 2 diabetes and fatty liver disease?
Conclusion
Semaglutide shows benefits in improving liver and vascular health in patients with type 2 diabetes.
Supporting Evidence
- Semaglutide improved controlled attenuation parameter and FIB-4 scores.
- Similar studies have shown semaglutide's benefits on liver health.
- GLP-1R agonists have hepatoprotective effects and improve liver function.
Takeaway
Semaglutide helps people with diabetes feel better by making their liver and blood vessels healthier.
Methodology
The study involved a 12-month follow-up with a treatment group receiving semaglutide and a control group receiving a different treatment.
Potential Biases
The treatment group was larger than the control group, which could lead to biased results.
Limitations
The small sample size and lack of true placebo may have limited the study's statistical power.
Participant Demographics
Patients with type 2 diabetes and fatty liver disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website